Key Takeaways
- Shares of Infleqtion surged 8.3% to reach $13.59 following Citi’s decision to lift its price target from $20 to $22 while maintaining a Buy recommendation.
- Wall Street analysts collectively assign a “Moderate Buy” rating with a consensus price objective of $20.60.
- The quantum technology firm fell short of Q2 projections, posting a per-share loss of $0.11 versus analyst expectations of $0.07.
- Company executives offloaded approximately 4 million shares valued at $64.8 million during the last quarter.
- Major institutional players established fresh positions in Q2, led by S&G Foundation’s substantial $154 million investment.
Shares of Infleqtion (INFQ) experienced an 8.3% surge on Friday, settling at $13.59, following Citi’s announcement that it was elevating its price projection for the quantum technology specialist from $20 to $22 while retaining its Buy recommendation.
During Friday’s session, the stock peaked at $13.61. Approximately 4.6 million shares changed hands, representing a 52% decline compared to the typical daily trading volume of 9.67 million shares.
The upward revision from Citi indicates the investment bank anticipates additional growth potential for Infleqtion. By maintaining its Buy recommendation, the firm continues to position the stock as a compelling investment option at present price levels.
Wall Street’s Perspective
Citi isn’t alone in its optimistic outlook. Wedbush Securities launched coverage on August 3rd, assigning an Outperform rating alongside a $20 price objective. Craig Hallum followed suit in July with a Buy recommendation and a $19 target price.
Zacks Investment Research elevated the stock to Hold status in late June. Conversely, Weiss Ratings initiated coverage with a Sell rating back in May.
The current breakdown shows one Strong Buy rating, five Buy recommendations, one Hold, and one Sell. This configuration yields a “Moderate Buy” consensus with an average price target of $20.60.
The company’s 50-day moving average stands at $11.77, while its market capitalization hovers around $3.02 billion. With a PE ratio of -92.13, the metric reflects the company’s current unprofitability.
Quarterly Results and Executive Transactions
Infleqtion unveiled its Q2 financial results on August 12th. The firm recorded a per-share loss of $0.11, falling short of the analyst consensus calling for a $0.07 loss by $0.04. Quarterly revenue reached $13.54 million.
Wall Street currently projects annual EPS of -$0.24 for Infleqtion’s full fiscal year.
Regarding insider transactions, Chief Executive Officer Matthew Kinsella divested 112,065 shares on May 26th at an average selling price of $15.56, generating approximately $1.74 million in proceeds. This transaction reduced his stake in the company by 25%.
Chief Revenue Officer Paul Lipman similarly sold 100,000 shares on the same date at $15.83 per share, totaling $1.58 million. This sale represented a 50% decrease in his direct ownership position.
Collectively, company insiders disposed of more than 4 million shares with a combined value of $64.8 million throughout the previous three-month period.
While insiders have been reducing their positions, major institutional investors have been building stakes. S&G Foundation established a new $154 million position during Q2. Davis Asset Management initiated a $27.8 million stake. Wellington Management added $3.7 million to its portfolio, while Bank of New York Mellon increased its holdings by more than 1,350%.
Year-to-date, Infleqtion’s share price has declined 19.55%, and technical indicators currently signal a Strong Sell.
Based on the most recent data, the company’s market capitalization stands at approximately $2.82 billion.





